JPMORGAN CHASE & CO
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 19617
NEW YORK, NY
Position in DMII
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,592,866
+$4,300,455 QoQ
Shares Held
685,581
+164.4% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 74 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026JPMORGAN CHASE & CO holds $131,664,739 across 160 Shell Companies names. DMII ranks #2 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KOYN |
CSLM Digital Asset Acquisition Corp III, Ltd
|
1,217,788 | $11,840,680 | |
| 2 | DMII |
Drugs Made In America Acquisition II Corp.
This page
|
685,581 | $5,592,866 | |
| 3 | ILLU |
Illumination Acquisition Corp. I
|
500,000 | $5,025,000 | |
| 4 | IACO |
Idea Acquisition Corp.
|
492,325 | $4,930,285 | |
| 5 | CEPF |
Cantor Equity Partners IV, Inc.
|
373,708 | $3,886,563 | |
| 6 | CAES |
Cantor Equity Partners VII, Inc.
|
355,195 | $3,583,917 | |
| 7 | ACAA |
Averin Capital Acquisition Corp.
|
356,824 | $3,147,199 | |
| 8 | SPEG |
Silver Pegasus Acquisition Corp.
|
299,747 | $3,078,401 |
All Filings in DMII
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,592,866 | 555,951 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,292,411 | 129,630 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,283,337 | 129,630 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||